FrankPHullMD

Internal Medicine • Plantation, FL

Critical Care Medicine, Sleep Medicine, Pulmonology

Pulmonologist & Sleep Medicine Specialist at Broward Pulmonary and Sleep Specialists

Join to view full profile

Dr. Hull is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hull's full profile

Already have an account?

Office
10059 NW 1st Ct
Plantation, FL 33324
Phone+1 954-522-7226

Fax+1 954-388-2222

Education & Training

NYU Grossman School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2001
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1994 - 1997
University of Pretoria Faculty of MedicineClass of 1990

Certifications & Licensure

FL State Medical License 2003 - 2025
NY State Medical License 2001 - 2005
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
American Board of Internal Medicine Sleep Medicine

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
Completed
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States Start of enrollment: 2017 Aug 03
Completed
Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. Start of enrollment: 2020 Jun 12
Completed
Phase 2
Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease Start of enrollment: 2020 May 28
Completed
Phase 2
Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level Start of enrollment: 2019 Oct 30
Active, not recruiting
Phase 3
A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis Start of enrollment: 2020 Dec 01
Active, not recruiting
Phase 3
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations Start of enrollment: 2022 Jan 03
Recruiting
Phase 3
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype Start of enrollment: 2021 Jan 26
Recruiting
Phase 3
BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging Start of enrollment: 2022 Oct 11
Active, not recruiting
Phase 4
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-2) Start of enrollment: 2021 Feb 12
Recruiting
Phase 3
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis Start of enrollment: 2024 Feb 20
Recruiting
Phase 2
BLU-5937: First-in-Human, Single and Multiple Doses Escalation, Safety, Tolerability, Pharmacokinetics and Food Effect Start of enrollment: 2018 Jul 09
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

35 citations
Regional Deposition of Aerosolized Interferon-γ in Pulmonary Tuberculosis
Rany Condos, Frank P. Hull, Neil W. Schluger, William N. Rom, Gerald C. Smaldone
Chest. 2004-06-01
1 citations
Best practices for implementing venous thromboembolism prophylaxis across the continuum of care.
Paul P. Dobesh, Tania Ahuja, George A. Davis, Hugh Fatodu, William H. Francis
The American Journal of Managed Care. 2018-11-01
Diagnosing pulmonary emboli: a critical review for the clinician and radiologist.
Yair Safriel, Frank Hull
The Yale Journal of Biology and Medicine. 2005-05-01

Journal Articles

Predicting Lung Deposition with a Cascade Impactor
Sangwan S, Hull F, CondosR, Smaldone GC, Journal of Aerosol Medicine, 2001
High Levels of Plasma IL-10 does not diminish purified protein derivative (PPD) skin induration size
FP Hull, R Condos, WN Rom, AJRCCM, 3/1999

Abstracts/Posters

Assessing Fatigue in Commercial Airline Pilots Using The Trail Making Test
Llewellyn Boyer-Cartwright, Stephanie Silberman Ph.D. , Frank Hull M.D., American Academy of Sleep Medicine, Denver, CO, 6/1/2005
Deposition of aerosolized interferon gamma in patients with tuberculosis & A novel method for measuring upper airway aerosol deeposition
F.P. Hull, R. Condos, W.N. Rom, G.C. Smaldone, American Thoracic Society (ATS) International Conference, San Francisco, CA, 2001
Clinical Efficacy Of Long Term Treatment With Pyrazinamide (PZA) In Multi Drug Resistant Tuberculosis (MDR-TB)
F.P. Hull, American Thoracic Society (ATS) International Conference, Toronto, Canada, 2000
High Levels of Plasma IL-10 does not diminish purified protein derivative (PPD) skin induration size
FP Hull, R Condos, WN Rom, American Thoracic Society International Conference, San Diego, CA, 5/1/1999
Join now to see all

Committees

Chair, Pharmacy and Therapeutic Committee, Kindred Fort Lauderdale 2008 - Present
Member, Cancer Committee, Broward Health Medical Center 2004 - Present
Chief of Staff, Medical Executive Committee, Kindred Fort Lauderdale 2011 - 2012